CardioNet, Inc. (BEAT)

[TheFinalCD]

https://ih.advfn.com/stock-market/NASDAQ/heartbeam-BEAT/stock-news/87941695/heartbeam-to-host-first-quarter-2022-results-confe

[mining101]

Super bullish

[mining101]

News

[mining101]

Woooooo

[TrendTrade2016]

BEAT gappa today...3.90 out of the gate!!

[TrendTrade2016]

BEAT low float showing its true colors!

[TrendTrade2016]

BEAT 4.38 up a head

[Jess070283]

Fill that gap!$$$$

[TrendTrade2016]

drums are beating now!!

[TrendTrade2016]

BEAT low floater showing signs

[TheFinalCD]

michael jackson just "_ _ _ _ " it

[TrendTrade2016]

BEAT the drums...we are starting to dance!!!!

[TrendTrade2016]

the drums are going to BEAT@@@@@@@@

[TrendTrade2016]

BEAT get ready to rumble.....in the jungle

[bcapps66]

The ticker for this stock is very appropriate....BEAT! As in BEAT the F**K UP.

[bcapps66]

What is wrong with this turd??

[BONGO68]

https://www.tipranks.com/stocks/beat/forecast

[BONGO68]

OVER 2,000,000 SOAKED UP OUT OF 7,000,000 OUTSTANDING SHARES THIS WEEK BY INSIDERS... SHOULD BE A HUGE BOUNCE ANY DAY... MAYBE BACK TO $73.00

[conix]

Hard to BEAT-- Black Friday deal

[conix]

Hard to BEAT

[Actualfactual]

Same here. Grabbed some 4.40’s to start

[honest dave]

BEAT trading $1.60 below IPO crazy. I'll take the bait.

[Bcl40004$]

Sorry to say BTCY is going to take some of BEat market share. REDWOOD CITY, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will be actively pursuing the Holter market in addition to the MCT market with its Bioflux product offering, expanding its revenue growth opportunities. Bioflux is a 3 in 1 monitoring solution, offering mobile cardiac telemetry (MCT), event, and Holter monitoring. Until now, the Company has primarily focused on the MCT market, recognizing that the future of patient monitoring lies in its real-time and remote capacities. This is because healthcare delivery is undergoing a seismic shift as connectivity becomes cheaper and ubiquitous, and as medical procedures and the point of care shifts to outpatient settings.

"We believe the future is in real-time, connected healthcare," said Mr. Waqaas Al-Siddiq, Biotricity Founder and CEO. "While MCT monitoring has always been the primary focus of our Bioflux solution, we are starting to realize that there is a significant demand for Holter services because many physicians value the traditional approach offered by short-term monitoring. As a result, we are now pursuing the entire cardiac arrhythmia market to expand our revenue growth opportunities."

Biotricity's unique Holter capability leverages the Company's mobile cardiac telemetry (MCT) technology and is connectivity-enabled, which means that physicians are able to ensure in real-time that patient data is being collected accurately during the prescribed study period. Traditional Holter monitors typically have no connectivity, which effectively precludes physicians from ensuring that patient data is being collected during a study period until after the study has been completed. With its Holter capability, Biotricity can access clear ECG traces on a Holter report at any time, ensuring the collection of high-fidelity patient data. Physicians whose patients are using Bioflux are able to initiate a Holter study and obtain a high-quality, full-featured Holter report through an automated portal workflow quickly and conveniently

[JohnCM]

BEAT monster stock

[ValueInvestor15]

Thinking of buying $BEAT on sell off... Trading at 25% discount to fair value


http://bit.ly/2cXjgsq

[crudeoil24]

No news; looks like shorts will have their turn.

[TheFinalCD]

WOW NICE



BEAT

[crudeoil24]

Volume spike; up 15% > pending news?

[crudeoil24]

BioTelemetry, Inc. Signs Definitive Agreement to Acquire VirtualScopics, Inc.
2 hours 19 minutes ago - DJNF

BioTelemetry, Inc. Signs Definitive Agreement to Acquire VirtualScopics, Inc.
MALVERN, Pa. and ROCHESTER, N.Y., March 25, 2016 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, and VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, announced today that the two companies have entered into a definitive agreement whereby BioTelemetry will acquire VirtualScopics.

BioTelemetry will commence an all cash tender offer for all outstanding common and preferred shares of VirtualScopics. In the tender offer, BioTelemetry will offer investors $4.05 per share for VirtualScopics' common stock, $336.30 per share for VirtualScopics' Series A and Series B Convertible Preferred Stock and $920.00 per share for VirtualScopics' Series C-1 Convertible Preferred Stock. The total purchase consideration is approximately $15.5 million.

The tender offer is expected to commence on or about April 11, 2016, and will be open for a minimum of 20 business days. VirtualScopics' Board has approved the transaction and has agreed to unanimously recommend to its stockholders that they tender their shares of VirtualScopics' common and preferred stock in the tender offer. Stockholders holding approximately 20% of VirtualScopics' current outstanding voting stock have agreed, among other things, to tender their voting stock pursuant to the tender offer.

The closing of the transaction is conditioned on the tender and acceptance of at least a majority of the outstanding voting stock and a majority of the Series C-1 Convertible Preferred Stock as well as other customary conditions. BioTelemetry will acquire any VirtualScopics' shares not purchased in the tender offer in a second-step merger at the same per-share price paid in the tender offer. The closing of the transaction is expected to occur in the second quarter of 2016.

VirtualScopics today reports revenue of $12.7 million for 2015. The Company expects to release its full 2015 financial results in its annual report on Form 10-K later today.

Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, commented: "We are excited to further expand our clinical research offerings with the addition of VirtualScopics' imaging capabilities. This acquisition demonstrates our continued commitment to growing our clinical research business. VirtualScopics possesses an excellent scientific and operational reputation and we look forward to building upon their longstanding relationships with their customers. We would like to welcome VirtualScopics' employees and customers to the BioTelemetry family and we look forward to the successful completion of the merger."

VirtualScopics' Chief Executive Officer, Eric Converse, added: "We believe BioTelemetry is the perfect partner for the future of VirtualScopics. They possess the scale and resources to accelerate our growth plan and lead the company into the future. This is an exciting time for everyone at VirtualScopics and we look forward to joining the BioTelemetry team."

Greenberg Traurig, LLP acted as legal counsel to BioTelemetry. Oppenheimer & Co. acted as exclusive financial advisor and Woods Oviatt Gilman LLP acted as legal counsel to VirtualScopics.

[jhamlin]

BEAT is at technical support now, earnings are growing, they are now profitable. I think it is a clear buy here at $12: http://techstockbull.com/biotelemetry-beat-is-undervalued-and-offers-investors-huge-upside-potential/

[BettingAngles]

$BEAT-Tomorrow back up!! Have a great evening!!

[BettingAngles]

BEAT-NICE!! http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=10507545-182644-186846&type=sect&TabIndex=2&dcn=0001047469-15-001062&nav=1&src=Yahoo

http://www.marketwatch.com/story/10-k-biotelemetry-inc-2015-02-23

http://ih.advfn.com/p.php?pid=nmona&article=65596423&symbol=BEAT

[BettingAngles]

$BEAT--Boomtime-Oversold..

[BettingAngles]

BEAT-Looks like a good time to load up..

[stocktrademan]

$BEAT DD Notes ~ http://www.ddnotesmaker.com/BEAT

bullish
good price action
hidden bullish divergence
higher highs and higher lows

$BEAT recent news/filings

## source: finance.yahoo.com

Fri, 21 Nov 2014 22:09:46 GMT ~ BIOTELEMETRY, INC. Files SEC form 8-K, Change in Directors or Principal Officers


read full: http://biz.yahoo.com/e/141121/beat8-k.html
*********************************************************

Wed, 19 Nov 2014 16:30:16 GMT ~ BioTelemetry, Inc. Announces That Eric Prystowsky M.D. Will Transition From the Board of Directors Into a Medical Advisory Role

[at noodls] - MALVERN, Pa., Nov. 19, 2014 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life ...

read full: http://www.noodls.com/view/B55A3F641D56F8209B98E0EDCBFB561E030D4901
*********************************************************

Wed, 19 Nov 2014 13:01:00 GMT ~ BioTelemetry, Inc. Announces That Eric Prystowsky M.D. Will Transition From the Board of Directors Into a Medical Advisory Role

[GlobeNewswire] - MALVERN, Pa. -- BioTelemetry, Inc. , the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that ...

read full: http://finance.yahoo.com/news/biotelemetry-inc-announces-eric-prystowsky-130100036.html
*********************************************************

Wed, 12 Nov 2014 12:57:54 GMT ~ Intrexon (XON) Looks Good: Stock Moves 11% Higher


read full: http://finance.yahoo.com/news/intrexon-xon-looks-good-stock-125754856.html
*********************************************************

Mon, 10 Nov 2014 11:09:44 GMT ~ Air Methods (AIRM) Crumbles: Stock Falls by 7.9%


read full: http://finance.yahoo.com/news/air-methods-airm-crumbles-stock-110944637.html
*********************************************************


$BEAT charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com


$BEAT company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/BEAT/company-info
Ticker: $BEAT
OTC Market Place: Not Available
CIK code: 0001113784
Company name: BioTelemetry, Inc.
Incorporated In: CA, USA

Business Description:


$BEAT share structure

## source: otcmarkets.com

Market Value: $233,248,238 a/o Nov 25, 2014
Shares Outstanding: 25,380,657 a/o Apr 25, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$BEAT extra dd links

Company name: BioTelemetry, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/BEAT/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/BEAT/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=BEAT+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=BEAT+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=BEAT+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/BEAT/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/BEAT/news - http://finance.yahoo.com/q/h?s=BEAT+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/BEAT/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/BEAT/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/BEAT/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/BEAT/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/BEAT/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/BEAT/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/BEAT/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/BEAT/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=BEAT+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/BEAT
DTCC (dtcc.com): http://search2.dtcc.com/?q=BioTelemetry%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=BioTelemetry%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=BioTelemetry%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/BEAT/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/BEAT
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/BEAT/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/BEAT/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/BEAT/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001113784&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/BEAT/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/BEAT/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/BEAT/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/BEAT/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=BEAT&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=BEAT
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/BEAT/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=BEAT+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=BEAT+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=BEAT
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=BEAT
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=BEAT+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/BEAT/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=BEAT+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/BEAT.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=BEAT
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/BEAT/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/BEAT/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/BEAT/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/BEAT/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/BEAT
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/BEAT
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/BEAT:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=BEAT
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=BEAT



$BEAT DD Notes ~ http://www.ddnotesmaker.com/BEAT

[gandalfq01]

Institution bought 1 million+ @$8
http://ih.advfn.com/p.php?pid=nmona&article=61000526

[kamdesigns1]

Can anyone explain the Form 25 just filed?

[Hole shot King]

$BEAT CardioNet, Inc. Announces Launch of MCOTos 2:1 Device

CardioNet, Inc. (Nasdaq:BEAT) ("CardioNet"), the leading wireless medical technology company focused on diagnosing and monitoring cardiac arrhythmias, announced today the launch of the MCOTos 2:1 device, providing both MCOTTM and wEvent monitoring capability in a single device. This added feature provides increased flexibility and convenience to both physicians and patients.

Joseph Capper, President and Chief Executive Officer of CardioNet, commented: "As part of our CardioNet Comprehensive strategy, we continue to develop solutions designed to serve all of the cardiac monitoring needs of our patients and practices. Consistent with this strategy, we are pleased to announce the latest addition to our cardiac monitoring device line-up, the MCOTos 2:1. With this device, we are able to offer either MCOTTM or wEvent monitoring, on demand, in the convenience of a single device. By combining these two life-saving technologies in one system, we are able to monitor patients more effectively, while providing increased efficiency and ease of use to our physicians. As evidenced with this latest introduction, we remain committed to providing our customers the best wireless cardiac monitoring solutions on the market."

http://www.globenewswire.com/news-release/2013/06/19/555217/10036892/en/CardioNet-Inc-Announces-Launch-of-MCOTos-2-1-Device.html

[Hole shot King]

RESULTS OF 13 POPULAR ANALYTICS

Overall Average: 96% Strong Buy

http://www.barchart.com/quotes/stocks/BEAT

[Stockexpertpro]

BEAT Secondary Stock Offering Coming?? Company is down to just 18 Million in Cash Company is losing MIllions right now would be a perfect time to do a secondary stock offering to raise some much needed cash

[Stockexpertpro]

BEAT Insiders Getting Shares for ZERO They are giving themselves shares for FREE and then dumping them into the open market why would anyone buy this trash when they are handing their insiders and employees shares at ZERO They are printing up shares and handing it like candy to their insiders and employees just giving shares away for FREE

Feb 18, 2013 BROADWAY FRED
Officer
14,820 Direct Acquisition (Non Open Market) at $0 per share. N/A
Feb 18, 2013 CAPPER JOSEPH H
Officer
128,400 Direct Acquisition (Non Open Market) at $0 per share. N/A
Feb 18, 2013 FEROLA PETER
Officer
16,800 Direct Acquisition (Non Open Market) at $0 per share. N/A
Feb 18, 2013 MCNAMARA ANNA
Officer
19,282 Direct Acquisition (Non Open Market) at $0 per share. N/A
Feb 18, 2013 GETZ HEATHER C
Officer
28,980 Direct Acquisition (Non Open Market) at $0 per share. N/A
Feb 18, 2013 HRENKO GEORGE
Officer
15,780 Direct Acquisition (Non Open Market) at $0 per share. N/A
Feb 18, 2013 WISNIEWSKI DANIEL
Officer
19,200 Direct Acquisition (Non Open Market) at $0 per share. N/A
Feb 18, 2013 AHRENS RONALD A
Director
5,000 Direct Purchase N/A
Feb 18, 2013 GELDART MICHAEL
Officer
19,200 Direct Acquisition (Non Open Market) at $0 per share. N/A
Nov 11, 2012 AHRENS RONALD A
Director
15,000 Direct Purchase at $2.22 per share. 33,300
Sep 4, 2012 BROADWAY FRED
Officer
35,077 Direct Statement of Ownership N/A
Sep 4, 2012 CAPPER JOSEPH H
Officer
10,745 Direct Automatic Purchase at $2.17 per share. 23,316
Sep 3, 2012 CAPPER JOSEPH H
Officer
12,795 Direct Automatic Purchase at $2.32 per share. 29,684
Aug 30, 2012 CAPPER JOSEPH H
Officer
2,600 Direct Automatic Purchase at $2.28 per share. 5,928
Aug 28, 2012 CAPPER JOSEPH H
Officer
10,800 Direct Automatic Purchase at $2.27 - $2.33 per share. 25,0002
Aug 27, 2012 CAPPER JOSEPH H
Officer
1,300 Direct Automatic Purchase at $2.19 per share. 2,847
Aug 26, 2012 CAPPER JOSEPH H
Officer
1,600 Direct Automatic Purchase at $2.12 per share. 3,391
Aug 23, 2012 CAPPER JOSEPH H
Officer
800 Direct Automatic Purchase at $2.13 per share. 1,704
Aug 22, 2012 CAPPER JOSEPH H
Officer
1,100 Direct Automatic Purchase at $2.11 per share. 2,321
Aug 21, 2012 CAPPER JOSEPH H
Officer
8,500 Direct Automatic Purchase at $2.08 per share. 17,680
Aug 20, 2012 CAPPER JOSEPH H
Officer
800 Direct Automatic Purchase at $2.01 per share. 1,608
Aug 19, 2012 CAPPER JOSEPH H
Officer
14,160 Direct Automatic Purchase at $1.97 per share. 27,895
Aug 16, 2012 CAPPER JOSEPH H
Officer
9,800 Direct Automatic Purchase at $2.10 per share. 20,580
Jun 10, 2012 GELDART MICHAEL
Officer
20,000 Direct Acquisition (Non Open Market) at $0 per share. N/A
May 6, 2012 RIMEL REBECCA W
Director
27,398 Direct Acquisition (Non Open Market) at $0 per share. N/A
May 6, 2012 AHRENS RONALD A
Director
49,660 Direct Acquisition (Non Open Market) at $0 per share. N/A
May 6, 2012 PRYSTOWSKY ERIC N
Director
27,398 Direct Acquisition (Non Open Market) at $0 per share. N/A
May 6, 2012 CONTI ANTHONY JAMES
Director
54,796 Direct Acquisition (Non Open Market) at $0 per share. N/A
May 6, 2012 RUBIN ROBERT J.
Director
38,958 Direct Acquisition (Non Open Market) at $0 per share. N/A
May 6, 2012 GORMAN KIRK E
Director
45,807 Direct Acquisition (Non Open Market) at $0 per share. N/A
Feb 20, 2012 GROPPER CHARLES
Officer
20,136 Direct Acquisition (Non Open Market) at $0 per share. N/A
Feb 20, 2012 FEROLA PETER
Officer
25,000 Direct Acquisition (Non Open Market) at $0 per share. N/A
Feb 20, 2012 CAPPER JOSEPH H
Officer
191,071 Direct Acquisition (Non Open Market) at $0 per share. N/A
Feb 20, 2012 GETZ HEATHER C
Officer
39,924 Direct Acquisition (Non Open Market) at $0 per share. N/A
Feb 20, 2012 KASRAWI JAREER
Officer
21,429 Direct Acquisition (Non Open Market) at $0 per share. N/A
Feb 20, 2012 SCHULER ANTHONY
Officer
20,645 Direct Acquisition (Non Open Market) at $0 per share. N/A
Feb 20, 2012 WISNIEWSKI DANIEL
Officer
28,571 Direct Acquisition (Non Open Market) at $0 per share. N/A
Feb 20, 2012 HRENKO GEORGE
Officer
23,482 Direct Acquisition (Non Open Market) at $0 per share. N/A
Feb 20, 2012 MCNAMARA ANNA
Officer
28,693 Direct Acquisition (Non Open Market) at $0 per share. N/

[Stockexpertpro]

BEAT Company Loss Nearly 100 Million Dollars over the past 3 years Company continues to lose Millions Medicare just reduced its reinbursement rates by 2% with further rate reductions coming in the future. The company is down to just 18 Million in Cash after burning through 28 Million Dollars last year The current market cap after the latest run up from 2$ a share to just over 6$ a share is a whopping 155 Million Dollars for a company that only has 18 Million in cash and that is losing Millions

The stock price up here is VERY BLOATED EXTREMLY Overbought

The company needs to do a secondary stock offering ASAP to take advantage and raise some much needed cash before they run out of money since they burned 28 Million in cash last year look at the balance sheet they had 28 Million in investments that is now gone they burned it all and are now down to just 18 Million in cash that want last long

Its been a very nice ride from 2$ to over 6$ in 2 short months but its time to get off this train and time to sell and lock those gains in greed kills in the stock market Lock those profits in and time to move the risk now is to the downside

[Hole shot King]

RESULTS OF 13 POPULAR ANALYTICS (BEAT)

Overall Average:100%

Strong Buy

http://www.barchart.com/quotes/stocks/BEAT

[Burmamonster]

How about tomorrow? :)

$BEAT

[otcbloodhound]

Today may be huge.....

[Wabi]

B.s. not the leading or largest

[Wabi]

Y would anyone sell .0001

[Wabi]

Cardionet leader in arrhythmia monitoring so I hear.

[Penny Roger$]

Weekly MFI on that chart I posted is turning to a positive this week. BEAT is making some nice progress.

[novicetrader]

And he continues buying,another Form 4 filed today for 14160 shares(per the stock purchase 10b5-1 Plan CEO will buy upto 75000 shares between August 17, 2012 through November 1, 2012 ):

http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=8784696-1175-9944&type=sect&TabIndex=2&companyid=123550&ppu=%252fdefault.aspx%253fcik%253d1113784